Estrogen Replacement May Reduce COVID-19 Death Risk
Estrogen supplementation is associated with a reduced risk of death from COVID-19 among postmenopausal women, new research suggests. Among postmenopausal women aged 50-80 years with verified COVID-19, those receiving estrogen as part of hormone replacement therapy (HRT) for menopausal symptoms were less than half as likely to die from it than those not receiving estrogen, even after adjustment for confounders.
@moupiya This is an observational study comparing three groups of women based on whether they used hormonal therapy to boost estrogen levels or who had, as a result of treatment for breast cancer...reduced estrogen levels or neither. The findings are apparently dramatic. At the very least, great caution should be exercised in thinking that menopausal hormone therapy will have substantial, or even any, benefits in dealing with COVID-19.